Weight cycling is a pattern in which individuals repeatedly lose and regain body weight. Researchers have found in a new ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Body-weight cycling, sometimes referred to as yo-yo dieting, may be harmful to the kidneys for people with type 1 diabetes, according to retrospective data analysis.

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Body weight cycling in type 1 diabetes is associated with increased risk of chronic kidney disease. Maintaining stable weight ...

as an add-on to standard care for the treatment of adults with stage 3 and 4 CKD associated with type 2 diabetes. Bayer has made digital health a core part of its offering to patients, alongside ...

A recent modeling study has identified risk factors predictive of good and bad outcomes in non-diabetic CKD, such as gender, race, and albuminuria.

Bone-Derived Hormone Predicts Diabetic ... Patients With CKD Lowering urate levels with urate-lowering therapy was not associated with an increased risk for severe or end-stage kidney disease ...

Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

kidney failure and death from cardiovascular events in patients with type 2 diabetes and chronic kidney disease. The agency cited findings from a late-stage trial by Novo Nordisk, which reported ...